FOXP3 and graft versus host disease: It has been shown in both human and mouse models that inhibition of ACC1, a potential mediator for de novo fatty acid synthesis, reduce Th17 development supporting the formation of anti-inflammatory Foxp3+ Tregs, suggesting the critical role of FAS to promote GVHD development.